You are looking at 1 - 8 of 8 items for :
- Policy/Advocacy x
- Funding x
- Refine by Content Type: News x
ASN and other groups are urging Congress and the Administration to make a critical investment in the nation’s health care delivery system by maintaining the 3.75% increase to the CF through at least calendar years 2022 and 2023.
Brian Hess, a lifelong kidney advocate, passed away on December 3, 2020.
Despite being diagnosed with kidney disease at a young age and undergoing dialysis for the majority of his life, Brian refused to let kidney disease slow him down. Brian graduated from the University of Central Oklahoma while maintaining his dialysis regime.
On behalf of the more than 40 million children, adolescents, and adults living with kidney diseases in the United States, the American Society of Nephrology (ASN) applauds the House Labor, Health and Human Services, Education, and Related Agencies Appropriations (LHHS) Subcommittee for their support of a Fiscal Year 2020 budget of $41.1 billion for the National Institutes of Health (NIH), an increase of $2 billion above the 2019 enacted level. ASN represents more than 20,000 physicians, scientists, nurses, and other health professionals dedicated to treating and studying kidney diseases to improve the lives of people with kidney diseases.
On Monday, April 29, the House Labor, Health and Human Services, Education, and Related Agencies Appropriations (LHHS) Subcommittee released their Fiscal Year 2020 budget. The draft provides a total of $41.1 billion for the National Institutes of Health (NIH), an increase of $2 billion above the 2019 enacted level and $6.9 billion above President Trump’s budget request.
The LHHS increase is a direct result of the countless emails, meetings, and phone calls made by members of the American Society of Nephrology (ASN) to their legislators and constitute a significant victory for the more than 40 million Americans living with kidney diseases. While the LHHS appropriations falls short of ASN’s request from earlier this year for $2.5 billion for NIH, with a proportional increase to the National Institute of Diabetes and Digestive Kidney Diseases (NIDDK), the appropriated increase is a welcome effort to sustain current research levels and keep pace with medical inflation.
Announced today during the 2019 inaugural KidneyX Summit, the House Appropriations Committee released the draft 2020 FY funding bill for Labor, Health and Human Services, Education, and Related Agencies (LHHS). The bill will be considered in subcommittee tomorrow, April 30th.
Importantly, for the Kidney Innovation Accelerator (KidneyX) , $10 million has been included in the bill for KidneyX, the public-private partnership between HHS and ASN “to accelerate the development and adoption of novel therapies and technologies to improve the diagnosis and treatment of kidney diseases.”
Advocates from the American Society of Nephrology (ASN) and the American Association of Kidney Patients (AAKP) are meeting with representatives, senators, and their respective staffs today, March 20th, to urge Congress to support KidneyX, a public-private partnership to accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases.
Several initiatives have been implemented by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the American Society of Nephrology (ASN) in order to foster kidney research and encourage research investigators as the NIH Division of Kidney, Urologic, & Hematologic Diseases (KUH) saw a 2% decrease in funding from the 2019 NIH budget.
Below is a list taken from an upcoming article in Kidney News March issue.
The American Society of Nephrology (ASN) organized the fourth Kidney Community Advocacy Day (KCAD) on Capitol Hill in Washington, DC, bringing together 13 organizations in the kidney community to raise the profile of kidney diseases with lawmakers. A total of 75 advocates representing a broad intersection of patient and provider perspectives from the kidney and transplant community met with nearly 100 members of Congress and their staff, commending them for investing in kidney research and asking for their support of the Living Donor Protection Act and increased innovation in kidney care through programs like KidneyX.